000 01461 a2200397 4500
005 20250513042720.0
264 0 _c19950628
008 199506s 0 0 eng d
022 _a0270-7306
024 7 _a10.1128/MCB.15.6.3049
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarnitz, L M
245 0 0 _aInterleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.
_h[electronic resource]
260 _bMolecular and cellular biology
_cJun 1995
300 _a3049-57 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAndrostadienes
_xpharmacology
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aMitogen-Activated Protein Kinase Kinases
650 0 4 _aPhosphatidylinositol 3-Kinases
650 0 4 _aPhosphotransferases (Alcohol Group Acceptor)
_xmetabolism
650 0 4 _aProtein Kinases
_xmetabolism
650 0 4 _aSecond Messenger Systems
650 0 4 _aSignal Transduction
650 0 4 _aT-Lymphocytes
_xmetabolism
650 0 4 _aWortmannin
700 1 _aBurns, L A
700 1 _aSutor, S L
700 1 _aBlenis, J
700 1 _aAbraham, R T
773 0 _tMolecular and cellular biology
_gvol. 15
_gno. 6
_gp. 3049-57
856 4 0 _uhttps://doi.org/10.1128/MCB.15.6.3049
_zAvailable from publisher's website
999 _c7760168
_d7760168